Biotechnology industry closing books

The closing books (or deal books) document stock offerings, mergers and acquisitions, and other financial transactions involving biotechnology companies. Most of the deals concern Genzyme Corporation and/or its subsidiaries. The books are typically divided into four parts: registration documents, sale and distribution documents, closing documents, and a miscellaneous section that usually consists of press releases and advertisements. The earlier stock offering deal books also contain tombstone advertisements, but after 1994 these are no longer included. The remainder of the books are on mergers with or purchase of other biotechnology companies, laboratories, or manufacturers. These books typically contain purchase documents, research, development, and/or consultation licenses and agreements, and the sale of the purchased company’s stock shares. All of the books contain correspondence between the respective parties, and all documents are usually replicated in duplicate or triplicate. There are sixty-seven volumes representing forty-two deals.